All Pharmaceutical Microbiology articles – Page 14
-
OpinionCatch-22: the FDA, probiotics, and preterm infants
As the FDA issues warning letters about probiotic products sold for use in hospitalized preterm infants, families of babies threatened by necrotizing enterocolitis (NEC) now face a deadly Catch-22 situation.
-
NewsFungus-fighting protein could help overcome severe autoimmune disease and cancer
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease (IBS) and type 1 diabetes.
-
NewsHIV drug could prevent coronaviruses, study finds
New research has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration.
-
NewsIce core proposal could revolutionise antibiotic discovery
A perspective article outlines a revolutionary approach to antibiotic discovery using ice cores, at a time when antimicrobial resistance (AMR) is projected to cause 10 million deaths per year by 2050.
-
NewsStudy reveals pain-relief pathways in disfiguring skin disease
For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don’t hurt.
-
NewsResearchers develop material that reduces bacterial infection and speeds up bone healing
Researchers have developed a new surgical implant that has the potential to transform the treatment of complex bone infections.
-
News Nano-sized cell particles are promising tool in treating infectious diseases
In a new study, extracellular vesicles were found to inhibit the viral infection of COVID-19 and potentially other infectious diseases.
-
NewsLong-acting biologic has transmucosal transport properties that arrest Covid variants
Scientists report on a tailored ACE2 biologic, where ACE2 is fused to an engineered human albumin variant.
-
NewsResearchers create molecule to tackle antimicrobial resistance
Researchers at Maynooth University, working as part of an international team, have created a new molecule that could help in the fight against drug-resistant bacteria. Source: Ella Maru Studios Researchers have created a new molecule to fight drug-resistant bacteria Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi ...
-
NewsResearchers shed light on how one deadly pathogen makes its chemicals
Scientists have deciphered a previously unidentified cluster of genes responsible for producing sartorypyrones, a chemical made by the fungal pathogen Aspergillus fumigatus, whose family causes Aspergillosis in humans.
-
NewsResearchers develop new approaches in the fight against drug resistance in malaria
Researchers have combined the anti-malaria drug artemisinin with coumarin, which, like artemisinin, is also found in plants, and developed an auto-fluorescent compound from both bioactive substances.
-
NewsQuick and easy method tests antimicrobial susceptibility
Scientists have successfully developed an electrical impedance-based microfluidic platform that provides rapid and accurate AMR evaluation within an hour.
-
NewsScientists to eliminate bottlenecks to breakthroughs with a new synthetic biology robotics system
Researchers in UC Santa Barbara’s newly designated Biological Engineering (BioE) Department have received a significant boost from the U.S. Army, which awarded a $9.85 million grant to design and purchase state-of-the-art equipment.
-
NewsPotential therapeutic target found to combat TB, a disrupted NAD(H) homeostasis
A study shows how Mycobacterium tuberculosis perturbs homeostasis of the high-energy molecule NADH and reprograms glycolysis in myeloid cells - highlighting glycolysis as a potential therapeutic target.
-
NewsSilver nanoparticles guarantee antimicrobial safe-tea
Researchers at the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS) have demonstrated green tea-silver nanoparticles as a powerful tool against pathogens such as bacteria and yeast.
-
NewsCancer therapy shows promise against tuberculosis
A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB).
-
NewsIridescentBio bringing virtual high-throughput assays to antibody R&D
IridescentBio is a new techbio start-up that’s bringing creative chemistry, physics know-how and methods to the Biopharma R&D world. The team of four are building computational models in the cloud to provide forecasting superpowers for lab-based research and development of antibody therapeutics. IridescentBio’s modelling framework is already ...
-
NewsNovel C. diff structures are required for infection and offer new therapeutic targets
Iron storage ‘spheres’ inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen.
-
NewsTiny hinges bend the infection-spreading spikes of a coronavirus
Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections, including COVID-19.
-
NewsBook scopes out marine natural compounds in search for anti-infective medicines
The latest volume of the Bentham Science book series, Frontiers in Antimicrobial Agents, scopes out the potential of marine natural compounds in the search for anti-infective medicines.